TY - JOUR AU - Vakkala, M. AU - Laurila, J. J. AU - Saarnio, J. AU - Koivukangas, V. AU - Syrjala, H. AU - Karttunen, T. AU - Soini, Y. AU - Ala-Kokko, T. I. PY - 2007 DA - 2007// TI - Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc6170 DO - 10.1186/cc6170 ID - Vakkala2007 ER - TY - JOUR AU - Ke, Q. AU - Costa, M. PY - 2006 DA - 2006// TI - Hypoxia-inducible factor-1 (HIF-1) JO - Mol Pharmacol VL - 70 UR - https://doi.org/10.1124/mol.106.027029 DO - 10.1124/mol.106.027029 ID - Ke2006 ER - TY - JOUR AU - Vincent, J. L. AU - Sakr, Y. AU - Sprung, C. L. AU - Ranieri, V. M. AU - Reinhart, K. AU - Gerlach, H. AU - Moreno, R. AU - Carlet, J. AU - Le Gall, J. R. AU - Payen, D. PY - 2006 DA - 2006// TI - Sepsis in European intensive care units: results of the SOAP study JO - Crit Care Med VL - 34 UR - https://doi.org/10.1097/01.CCM.0000194725.48928.3A DO - 10.1097/01.CCM.0000194725.48928.3A ID - Vincent2006 ER - TY - JOUR AU - Engel, C. AU - Brunkhorst, F. M. AU - Bone, H. G. AU - Brunkhorst, R. AU - Gerlach, H. AU - Grond, S. AU - Gruendling, M. AU - Huhle, G. AU - Jaschinski, U. AU - John, S. AU - Mayer, K. AU - Oppert, M. AU - Olthoff, D. AU - Quintel, M. AU - Ragaller, M. AU - Rossaint, R. AU - Stuber, F. AU - Weiler, N. AU - Welte, T. AU - Bogatsch, H. AU - Hartog, C. AU - Loeffler, M. AU - Reinhart, K. PY - 2007 DA - 2007// TI - Epidemiology of sepsis in Germany: results from a national prospective multicenter study JO - Intensive Care Med VL - 33 UR - https://doi.org/10.1007/s00134-006-0517-7 DO - 10.1007/s00134-006-0517-7 ID - Engel2007 ER - TY - JOUR AU - Hotchkiss, R. S. AU - Karl, I. E. PY - 2003 DA - 2003// TI - The pathophysiology and treatment of sepsis JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMra021333 DO - 10.1056/NEJMra021333 ID - Hotchkiss2003 ER - TY - JOUR AU - Sriskandan, S. AU - Altmann, D. M. PY - 2008 DA - 2008// TI - The immunology of sepsis JO - J Pathol VL - 214 UR - https://doi.org/10.1002/path.2274 DO - 10.1002/path.2274 ID - Sriskandan2008 ER - TY - JOUR AU - Boman, H. G. PY - 2003 DA - 2003// TI - Antibacterial peptides: basic facts and emerging concepts JO - J Intern Med VL - 254 UR - https://doi.org/10.1046/j.1365-2796.2003.01228.x DO - 10.1046/j.1365-2796.2003.01228.x ID - Boman2003 ER - TY - JOUR AU - Yang, D. AU - Biragyn, A. AU - Kwak, L. W. AU - Oppenheim, J. J. PY - 2002 DA - 2002// TI - Mammalian defensins in immunity: more than just microbicidal JO - Trends Immunol VL - 23 UR - https://doi.org/10.1016/S1471-4906(02)02246-9 DO - 10.1016/S1471-4906(02)02246-9 ID - Yang2002 ER - TY - JOUR AU - Book, M. AU - Chen, Q. AU - Lehmann, L. E. AU - Klaschik, S. AU - Weber, S. AU - Schewe, J. C. AU - Luepertz, M. AU - Hoeft, A. AU - Stuber, F. PY - 2007 DA - 2007// TI - Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc5694 DO - 10.1186/cc5694 ID - Book2007 ER - TY - JOUR AU - Brodsky, S. V. AU - Zhang, F. AU - Nasjletti, A. AU - Goligorsky, M. S. PY - 2004 DA - 2004// TI - Endothelium-derived microparticles impair endothelial function in vitro JO - Am J Physiol Heart Circ Physiol VL - 286 UR - https://doi.org/10.1152/ajpheart.01172.2003 DO - 10.1152/ajpheart.01172.2003 ID - Brodsky2004 ER - TY - JOUR AU - Meziani, F. AU - Tesse, A. AU - Andriantsitohaina, R. PY - 2008 DA - 2008// TI - Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases JO - Pharmacol Rep VL - 60 ID - Meziani2008 ER - TY - JOUR AU - Piccin, A. AU - Murphy, W. G. AU - Smith, O. P. PY - 2007 DA - 2007// TI - Circulating microparticles: pathophysiology and clinical implications JO - Blood Rev VL - 21 UR - https://doi.org/10.1016/j.blre.2006.09.001 DO - 10.1016/j.blre.2006.09.001 ID - Piccin2007 ER - TY - JOUR AU - Janiszewski, M. AU - Do Carmo, A. O. AU - Pedro, M. A. AU - Silva, E. AU - Knobel, E. AU - Laurindo, F. R. PY - 2004 DA - 2004// TI - Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: a novel vascular redox pathway JO - Crit Care Med VL - 32 UR - https://doi.org/10.1097/01.CCM.0000114829.17746.19 DO - 10.1097/01.CCM.0000114829.17746.19 ID - Janiszewski2004 ER - TY - JOUR AU - Gambim, M. H. AU - do Carmo, A. O. AU - Marti, L. AU - Verissimo-Filho, S. AU - Lopes, L. R. AU - Janiszewski, M. PY - 2007 DA - 2007// TI - Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc6133 DO - 10.1186/cc6133 ID - Gambim2007 ER - TY - JOUR AU - Azevedo, L. C. AU - Janiszewski, M. AU - Soriano, F. G. AU - Laurindo, F. R. PY - 2006 DA - 2006// TI - Redox mechanisms of vascular cell dysfunction in sepsis JO - Endocr Metab Immune Disord Drug Targets VL - 6 UR - https://doi.org/10.2174/187153006777442431 DO - 10.2174/187153006777442431 ID - Azevedo2006 ER - TY - JOUR AU - Wang, H. AU - Bloom, O. AU - Zhang, M. AU - Vishnubhakat, J. M. AU - Ombrellino, M. AU - Che, J. AU - Frazier, A. AU - Yang, H. AU - Ivanova, S. AU - Borovikova, L. AU - Manogue, K. R. AU - Faist, E. AU - Abraham, E. AU - Andersson, J. AU - Andersson, U. AU - Molina, P. E. AU - Abumrad, N. N. AU - Sama, A. AU - Tracey, K. J. PY - 1999 DA - 1999// TI - HMG-1 as a late mediator of endotoxin lethality in mice JO - Science VL - 285 UR - https://doi.org/10.1126/science.285.5425.248 DO - 10.1126/science.285.5425.248 ID - Wang1999 ER - TY - JOUR AU - Parrish, W. AU - Ulloa, L. PY - 2007 DA - 2007// TI - High-mobility group box-1 isoforms as potential therapeutic targets in sepsis JO - Methods Mol Biol VL - 361 ID - Parrish2007 ER - TY - JOUR AU - Wang, H. AU - Li, W. AU - Goldstein, R. AU - Tracey, K. J. AU - Sama, A. E. PY - 2007 DA - 2007// TI - HMGB1 as a potential therapeutic target JO - Novartis Found Symp VL - 280 UR - https://doi.org/10.1002/9780470059593.ch6 DO - 10.1002/9780470059593.ch6 ID - Wang2007 ER - TY - JOUR AU - Zweigner, J. AU - Schumann, R. R. AU - Weber, J. R. PY - 2006 DA - 2006// TI - The role of lipopolysaccharide-binding protein in modulating the innate immune response JO - Microbes Infect VL - 8 UR - https://doi.org/10.1016/j.micinf.2005.10.006 DO - 10.1016/j.micinf.2005.10.006 ID - Zweigner2006 ER - TY - JOUR AU - Assicot, M. AU - Gendrel, D. AU - Carsin, H. AU - Raymond, J. AU - Guilbaud, J. AU - Bohuon, C. PY - 1993 DA - 1993// TI - High serum procalcitonin concentrations in patients with sepsis and infection JO - Lancet VL - 341 UR - https://doi.org/10.1016/0140-6736(93)90277-N DO - 10.1016/0140-6736(93)90277-N ID - Assicot1993 ER - TY - JOUR AU - Gaini, S. AU - Koldkjaer, O. G. AU - Moller, H. J. AU - Pedersen, C. AU - Pedersen, S. S. PY - 2007 DA - 2007// TI - A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc5967 DO - 10.1186/cc5967 ID - Gaini2007 ER - TY - JOUR AU - Nobre, V. AU - Harbarth, S. AU - Graf, J. D. AU - Rohner, P. AU - Pugin, J. PY - 2008 DA - 2008// TI - Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial JO - Am J Respir Crit Care Med VL - 177 UR - https://doi.org/10.1164/rccm.200708-1238OC DO - 10.1164/rccm.200708-1238OC ID - Nobre2008 ER - TY - JOUR AU - Ibrahim, E. H. AU - Sherman, G. AU - Ward, S. AU - Fraser, V. J. AU - Kollef, M. H. PY - 2000 DA - 2000// TI - The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting JO - Chest VL - 118 UR - https://doi.org/10.1378/chest.118.1.146 DO - 10.1378/chest.118.1.146 ID - Ibrahim2000 ER - TY - JOUR AU - Kumar, A. AU - Roberts, D. AU - Wood, K. E. AU - Light, B. AU - Parrillo, J. E. AU - Sharma, S. AU - Suppes, R. AU - Feinstein, D. AU - Zanotti, S. AU - Taiberg, L. AU - Gurka, D. AU - Kumar, A. AU - Cheang, M. PY - 2006 DA - 2006// TI - Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock JO - Crit Care Med VL - 34 UR - https://doi.org/10.1097/01.CCM.0000217961.75225.E9 DO - 10.1097/01.CCM.0000217961.75225.E9 ID - Kumar2006 ER - TY - JOUR AU - Gattinoni, L. AU - Brazzi, L. AU - Pelosi, P. AU - Latini, R. AU - Tognoni, G. AU - Pesenti, A. AU - Fumagalli, R. PY - 1995 DA - 1995// TI - A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group JO - N Engl J Med VL - 333 UR - https://doi.org/10.1056/NEJM199510193331601 DO - 10.1056/NEJM199510193331601 ID - Gattinoni1995 ER - TY - JOUR AU - Heyland, D. K. AU - Cook, D. J. AU - King, D. AU - Kernerman, P. AU - Brun-Buisson, C. PY - 1996 DA - 1996// TI - Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence JO - Crit Care Med VL - 24 UR - https://doi.org/10.1097/00003246-199603000-00025 DO - 10.1097/00003246-199603000-00025 ID - Heyland1996 ER - TY - JOUR AU - Rivers, E. AU - Nguyen, B. AU - Havstad, S. AU - Ressler, J. AU - Muzzin, A. AU - Knoblich, B. AU - Peterson, E. AU - Tomlanovich, M. PY - 2001 DA - 2001// TI - Early goal-directed therapy in the treatment of severe sepsis and septic shock JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa010307 DO - 10.1056/NEJMoa010307 ID - Rivers2001 ER - TY - JOUR AU - McIntyre, L. A. AU - Hebert, P. C. AU - Fergusson, D. AU - Cook, D. J. AU - Aziz, A. PY - 2007 DA - 2007// TI - A survey of Canadian intensivists' resuscitation practices in early septic shock JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc5962 DO - 10.1186/cc5962 ID - McIntyre2007 ER - TY - JOUR AU - Hebert, P. C. AU - Wells, G. AU - Blajchman, M. A. AU - Marshall, J. AU - Martin, C. AU - Pagliarello, G. AU - Tweeddale, M. AU - Schweitzer, I. AU - Yetisir, E. PY - 1999 DA - 1999// TI - A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199902113400601 DO - 10.1056/NEJM199902113400601 ID - Hebert1999 ER - TY - JOUR AU - Raghavan, M. AU - Marik, P. E. PY - 2005 DA - 2005// TI - Anemia, allogenic blood transfusion, and immunomodulation in the critically ill JO - Chest VL - 127 UR - https://doi.org/10.1378/chest.127.1.295 DO - 10.1378/chest.127.1.295 ID - Raghavan2005 ER - TY - JOUR AU - Brunkhorst, F. M. AU - Engel, C. AU - Bloos, F. AU - Meier-Hellmann, A. AU - Ragaller, M. AU - Weiler, N. AU - Moerer, O. AU - Gruendling, M. AU - Oppert, M. AU - Grond, S. AU - Olthoff, D. AU - Jaschinski, U. AU - John, S. AU - Rossaint, R. AU - Welte, T. AU - Schaefer, M. AU - Kern, P. AU - Kuhnt, E. AU - Kiehntopf, M. AU - Hartog, C. AU - Natanson, C. AU - Loeffler, M. AU - Reinhart, K. PY - 2008 DA - 2008// TI - Intensive insulin therapy and pentastarch resuscitation in severe sepsis JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa070716 DO - 10.1056/NEJMoa070716 ID - Brunkhorst2008 ER - TY - STD TI - Evidence-based colloid use in the critically ill: American Thoracic Society Consensus StatementAm J Respir Crit Care Med 2004, 170: 1247-1259. ID - ref32 ER - TY - JOUR AU - Barron, M. E. AU - Wilkes, M. M. AU - Navickis, R. J. PY - 2004 DA - 2004// TI - A systematic review of the comparative safety of colloids JO - Arch Surg VL - 139 UR - https://doi.org/10.1001/archsurg.139.5.552 DO - 10.1001/archsurg.139.5.552 ID - Barron2004 ER - TY - JOUR AU - Ouderkirk, J. P. AU - Nord, J. A. AU - Turett, G. S. AU - Kislak, J. W. PY - 2003 DA - 2003// TI - Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria JO - Antimicrob Agents Chemother VL - 47 UR - https://doi.org/10.1128/AAC.47.8.2659-2662.2003 DO - 10.1128/AAC.47.8.2659-2662.2003 ID - Ouderkirk2003 ER - TY - JOUR AU - Cruz, D. N. AU - Perazella, M. A. AU - Bellomo, R. AU - de Cal, M. AU - Polanco, N. AU - Corradi, V. AU - Lentini, P. AU - Nalesso, F. AU - Ueno, T. AU - Ranieri, V. M. AU - Ronco, C. PY - 2007 DA - 2007// TI - Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc5780 DO - 10.1186/cc5780 ID - Cruz2007 ER - TY - JOUR AU - Bernard, G. R. AU - Vincent, J. L. AU - Laterre, P. F. AU - LaRosa, S. P. AU - Dhainaut, J. F. AU - Lopez-Rodriguez, A. AU - Steingrub, J. S. AU - Garber, G. E. AU - Helterbrand, J. D. AU - Ely, E. W. AU - Fisher, C. J. PY - 2001 DA - 2001// TI - Efficacy and safety of recombinant human activated protein C for severe sepsis JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103083441001 DO - 10.1056/NEJM200103083441001 ID - Bernard2001 ER - TY - JOUR AU - Sprung, C. L. AU - Annane, D. AU - Keh, D. AU - Moreno, R. AU - Singer, M. AU - Freivogel, K. AU - Weiss, Y. G. AU - Benbenishty, J. AU - Kalenka, A. AU - Forst, H. AU - Laterre, P. F. AU - Reinhart, K. AU - Cuthbertson, B. H. AU - Payen, D. AU - Briegel, J. PY - 2008 DA - 2008// TI - Hydrocortisone therapy for patients with septic shock JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa071366 DO - 10.1056/NEJMoa071366 ID - Sprung2008 ER - TY - JOUR AU - Wischmeyer, P. E. AU - Lynch, J. AU - Liedel, J. AU - Wolfson, R. AU - Riehm, J. AU - Gottlieb, L. AU - Kahana, M. PY - 2001 DA - 2001// TI - Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control JO - Crit Care Med VL - 29 UR - https://doi.org/10.1097/00003246-200111000-00006 DO - 10.1097/00003246-200111000-00006 ID - Wischmeyer2001 ER - TY - JOUR AU - Wischmeyer, P. E. AU - Kahana, M. AU - Wolfson, R. AU - Ren, H. AU - Musch, M. M. AU - Chang, E. B. PY - 2001 DA - 2001// TI - Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia JO - Shock VL - 16 UR - https://doi.org/10.1097/00024382-200116050-00014 DO - 10.1097/00024382-200116050-00014 ID - Wischmeyer2001 ER - TY - JOUR AU - Singleton, K. D. AU - Serkova, N. AU - Banerjee, A. AU - Meng, X. AU - Gamboni-Robertson, F. AU - Wischmeyer, P. E. PY - 2005 DA - 2005// TI - Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70 JO - Nutrition VL - 21 UR - https://doi.org/10.1016/j.nut.2004.05.023 DO - 10.1016/j.nut.2004.05.023 ID - Singleton2005 ER - TY - JOUR AU - Lindquist, S. AU - Craig, E. A. PY - 1988 DA - 1988// TI - The heat-shock proteins JO - Annu Rev Genet VL - 22 UR - https://doi.org/10.1146/annurev.ge.22.120188.003215 DO - 10.1146/annurev.ge.22.120188.003215 ID - Lindquist1988 ER - TY - JOUR AU - Ang, D. AU - Liberek, K. AU - Skowyra, D. AU - Zylicz, M. AU - Georgopoulos, C. PY - 1991 DA - 1991// TI - Biological role and regulation of the universally conserved heat shock proteins JO - J Biol Chem VL - 266 ID - Ang1991 ER - TY - JOUR AU - Jing, L. AU - Wu, Q. AU - Wang, F. PY - 2007 DA - 2007// TI - Glutamine induces heat-shock protein and protects against Escherichia coli lipopolysaccharide-induced vascular hyporeactivity in rats JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc5717 DO - 10.1186/cc5717 ID - Jing2007 ER - TY - JOUR AU - Quartin, A. A. AU - Schein, R. M. AU - Kett, D. H. AU - Peduzzi, P. N. PY - 1997 DA - 1997// TI - Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group JO - JAMA VL - 277 UR - https://doi.org/10.1001/jama.1997.03540370048035 DO - 10.1001/jama.1997.03540370048035 ID - Quartin1997 ER - TY - JOUR AU - Graf, J. AU - Koch, M. AU - Dujardin, R. AU - Kersten, A. AU - Janssens, U. PY - 2003 DA - 2003// TI - Health-related quality of life before, 1 month after, and 9 months after intensive care in medical cardiovascular and pulmonary patients JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/01.CCM.0000079607.87009.3A DO - 10.1097/01.CCM.0000079607.87009.3A ID - Graf2003 ER - TY - JOUR AU - Granja, C. AU - Dias, C. AU - Costa-Pereira, A. AU - Sarmento, A. PY - 2004 DA - 2004// TI - Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness JO - Crit Care VL - 8 UR - https://doi.org/10.1186/cc2818 DO - 10.1186/cc2818 ID - Granja2004 ER - TY - JOUR AU - Korosec, J. H. AU - Jagodic, K. AU - Podbregar, M. PY - 2006 DA - 2006// TI - Long-term outcome and quality of life of patients treated in surgical intensive care: a comparison between sepsis and trauma JO - Crit Care VL - 10 UR - https://doi.org/10.1186/cc5047 DO - 10.1186/cc5047 ID - Korosec2006 ER - TY - JOUR AU - Erickson, S. E. AU - Martin, G. S. PY - 2008 DA - 2008// TI - Effect of sepsis therapies on health-related quality of life JO - Crit Care VL - 12 UR - https://doi.org/10.1186/cc6215 DO - 10.1186/cc6215 ID - Erickson2008 ER - TY - JOUR AU - Garcia, L. F. AU - Peres, B. D. AU - De Cubber, M. AU - Vincent, J. L. PY - 2003 DA - 2003// TI - Long-term outcome in ICU patients: what about quality of life? JO - Intensive Care Med VL - 29 UR - https://doi.org/10.1007/s00134-003-1875-z DO - 10.1007/s00134-003-1875-z ID - Garcia2003 ER - TY - JOUR AU - Longo, C. J. AU - Heyland, D. K. AU - Fisher, H. N. AU - Fowler, R. A. AU - Martin, C. M. AU - Day, A. G. PY - 2007 DA - 2007// TI - A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care JO - Crit Care VL - 11 UR - https://doi.org/10.1186/cc6195 DO - 10.1186/cc6195 ID - Longo2007 ER - TY - JOUR AU - Herridge, M. S. PY - 2007 DA - 2007// TI - Long-term outcomes after critical illness: past, present, future JO - Curr Opin Crit Care VL - 13 UR - https://doi.org/10.1097/MCC.0b013e3282eff3af DO - 10.1097/MCC.0b013e3282eff3af ID - Herridge2007 ER - TY - JOUR AU - Herridge, M. S. AU - Cheung, A. M. AU - Tansey, C. M. AU - Matte-Martyn, A. AU - Diaz-Granados, N. AU - Al-Saidi, F. AU - Cooper, A. B. AU - Guest, C. B. AU - Mazer, C. D. AU - Mehta, S. AU - Stewart, T. E. AU - Barr, A. AU - Cook, D. AU - Slutsky, A. S. PY - 2003 DA - 2003// TI - One-year outcomes in survivors of the acute respiratory distress syndrome JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa022450 DO - 10.1056/NEJMoa022450 ID - Herridge2003 ER - TY - JOUR AU - Herridge, M. S. PY - 2002 DA - 2002// TI - Long-term outcomes after critical illness JO - Curr Opin Crit Care VL - 8 UR - https://doi.org/10.1097/00075198-200208000-00010 DO - 10.1097/00075198-200208000-00010 ID - Herridge2002 ER - TY - JOUR AU - Banks, S. M. AU - Gerstenberger, E. AU - Eichacker, P. Q. AU - Natanson, C. PY - 2003 DA - 2003// TI - Long-term cost effectiveness of drotrecogin alfa (activated): an unanswered question JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/00003246-200301000-00050 DO - 10.1097/00003246-200301000-00050 ID - Banks2003 ER - TY - JOUR AU - Angus, D. C. AU - Linde-Zwirble, W. T. AU - Clermont, G. AU - Ball, D. E. AU - Basson, B. R. AU - Ely, E. W. AU - Laterre, P. F. AU - Vincent, J. L. AU - Bernard, G. AU - van Hout, B. PY - 2003 DA - 2003// TI - Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/00003246-200301000-00001 DO - 10.1097/00003246-200301000-00001 ID - Angus2003 ER - TY - JOUR AU - Davies, A. AU - Ridley, S. AU - Hutton, J. AU - Chinn, C. AU - Barber, B. AU - Angus, D. C. PY - 2005 DA - 2005// TI - Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom JO - Anaesthesia VL - 60 UR - https://doi.org/10.1111/j.1365-2044.2004.04068.x DO - 10.1111/j.1365-2044.2004.04068.x ID - Davies2005 ER - TY - JOUR AU - Neilson, A. R. AU - Burchardi, H. AU - Chinn, C. AU - Clouth, J. AU - Schneider, H. AU - Angus, D. PY - 2003 DA - 2003// TI - Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany JO - J Crit Care VL - 18 UR - https://doi.org/10.1016/j.jcrc.2003.10.005 DO - 10.1016/j.jcrc.2003.10.005 ID - Neilson2003 ER - TY - JOUR AU - Frampton, J. E. AU - Foster, R. H. PY - 2004 DA - 2004// TI - Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis JO - Pharmacoeconomics VL - 22 UR - https://doi.org/10.2165/00019053-200422070-00004 DO - 10.2165/00019053-200422070-00004 ID - Frampton2004 ER - TY - JOUR AU - Green, C. AU - Dinnes, J. AU - Takeda, A. L. AU - Cuthbertson, B. H. PY - 2006 DA - 2006// TI - Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom JO - Int J Technol Assess Health Care VL - 22 UR - https://doi.org/10.1017/S0266462306050884 DO - 10.1017/S0266462306050884 ID - Green2006 ER - TY - JOUR AU - Manns, B. J. AU - Lee, H. AU - Doig, C. J. AU - Johnson, D. AU - Donaldson, C. PY - 2002 DA - 2002// TI - An economic evaluation of activated protein C treatment for severe sepsis JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMsa020969 DO - 10.1056/NEJMsa020969 ID - Manns2002 ER -